Variant report
Variant | nsv982125 |
---|---|
Chromosome Location | chr8:65245389-65256068 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs146491282 | chr8:65245414-65245415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs181098435 | chr8:65245464-65245465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs199859198 | chr8:65245482-65245483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs542673730 | chr8:65245511-65245512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs72652691 | chr8:65245522-65245523 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs140890481 | chr8:65245525-65245526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs568855619 | chr8:65245582-65245583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs563079089 | chr8:65245585-65245586 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs533619809 | chr8:65245663-65245664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs545366625 | chr8:65245665-65245666 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs560871694 | chr8:65245687-65245688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs116403842 | chr8:65245697-65245698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs535521997 | chr8:65245728-65245729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs74746038 | chr8:65245745-65245746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs118045420 | chr8:65245798-65245799 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs199941804 | chr8:65245805-65245806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs531700460 | chr8:65245865-65245866 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs557928102 | chr8:65245878-65245879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs548191156 | chr8:65245954-65245955 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs538863124 | chr8:65245987-65245988 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs77668288 | chr8:65246025-65246026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs138526155 | chr8:65246066-65246067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs536222100 | chr8:65246108-65246109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs554618204 | chr8:65246141-65246142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs576160870 | chr8:65246253-65246254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs543541949 | chr8:65246254-65246255 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs75308779 | chr8:65246290-65246291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs80004903 | chr8:65246337-65246338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs180938725 | chr8:65246360-65246361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs186056299 | chr8:65246370-65246371 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs149255991 | chr8:65246386-65246387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs572601024 | chr8:65246398-65246399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs112967587 | chr8:65246421-65246422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs148159087 | chr8:65246432-65246433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs531637018 | chr8:65246454-65246455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs568089069 | chr8:65246485-65246486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs192220004 | chr8:65246628-65246629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs7844448 | chr8:65246637-65246638 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs12550006 | chr8:65246652-65246653 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs567175468 | chr8:65246698-65246699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs142016246 | chr8:65246703-65246704 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs184056357 | chr8:65246715-65246716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs74978659 | chr8:65246783-65246784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs565798201 | chr8:65246805-65246806 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs71529128 | chr8:65246811-65246812 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs538857174 | chr8:65246814-65246815 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs114763386 | chr8:65246820-65246821 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs554952871 | chr8:65246830-65246831 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs569658006 | chr8:65246900-65246901 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs537075948 | chr8:65247009-65247010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Colorectal cancer | 21645411 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Renal cell carcinoma | 21215367 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:65236400-65248000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr8:65248000-65249600 | Strong transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr8:65248200-65248800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
4 | chr8:65248200-65249000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
5 | chr8:65249600-65260000 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr8:65251400-65253800 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr8:65253800-65254600 | Strong transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr8:65254200-65255200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr8:65254400-65255600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
10 | chr8:65254600-65255200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
11 | chr8:65254600-65257200 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr8:65255200-65255400 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |